Therma Bright IncTSXV:THRMView on OTCQB
- LAST PRICE0.0250
- TODAY'S CHANGE (%)-0.0050 (-16.6667%)
- Bid / Lots0.0250/ 642
- Ask / Lots0.0300/ 1,830
- Open / Previous Close0.0300 / 0.0300
- Day Range
- 52 Week Range
- Volume2,644,212
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | THRM |
|---|---|---|
| 09:32 ET | 850000 | 0.03 |
| 09:33 ET | 100000 | 0.03 |
| 09:35 ET | 40000 | 0.03 |
| 09:46 ET | 69000 | 0.03 |
| 10:06 ET | 27000 | 0.025 |
| 10:15 ET | 746000 | 0.025 |
| 10:18 ET | 14000 | 0.025 |
| 10:20 ET | 3000 | 0.02 |
| 10:26 ET | 306000 | 0.025 |
| 10:54 ET | 10000 | 0.025 |
| 11:20 ET | 76000 | 0.025 |
| 11:21 ET | 2000 | 0.025 |
| 11:34 ET | 15000 | 0.025 |
| 11:38 ET | 7000 | 0.02 |
| 11:39 ET | 105000 | 0.025 |
| 11:45 ET | 223000 | 0.025 |
| 11:50 ET | 25000 | 0.025 |
| 12:08 ET | 24000 | 0.025 |
Nov 11, 2024
Therma Bright Announces Shares for Debt Issuance, from 5:02PM ET on Monday Nov 11, 2024 by Dow Jones
5:02PM ET on Monday Nov 11, 2024 by Dow Jones
Oct 28, 2024
Oct 18, 2024
Therma Bright Announces Shares for Debt Issuance, from 5:01PM ET on Friday Oct 18, 2024 by Dow Jones
5:01PM ET on Friday Oct 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Therma Bright Inc | 12.6M | -2.5x | --- |
Medx Health Corp | 14.8M | -3.2x | --- |
Izotropic Corp | 3.4M | -1.2x | --- |
VentriPoint Diagnostics Ltd | 22.6M | -4.4x | --- |
Pangenomic Health Inc | 2.6M | -0.4x | --- |
EvokAI Creative Labs Inc | 2.3M | -0.2x | --- |
Company Information
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.
Contact Information
- Headquarters
- 345 Danforth AvenueTORONTO, ON, Canada M4K 1N7
- Phone
- 416-867-2353
- Fax
- 416-867-4566
Executives
- President, Chief Executive Officer, Director
- Rob Fia
- Chief Financial Officer
- Eric Myung
- Independent Director
- Joseph Heng
- Independent Director
- Spencer Huh
- Independent Director
- Tim Peterson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.6M |
|---|---|
Revenue (TTM) | $25.9K |
Shares Outstanding | 420.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.97 |
EPS | $-0.01 |
Book Value | $0.00 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 488.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -9,906.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
